EnricoPiccinini

Interested in #rare disease #ATMP #orphan drugs #biotech #genomics #startup #healthcare. Enjoying mountains; modern art oldest passion #MTAMO

[EnricoPiccinini @EpPiccinini]

Wonderful project https://t.co/tJlLNnqm8P

[EnricoPiccinini @EpPiccinini]

https://t.co/cd58d0LPGs

[EnricoPiccinini @EpPiccinini]

Any day, the Rare Disease day!

[EnricoPiccinini @EpPiccinini]

Best Wishes to all!!!

[Chiesi Group @ChiesiGroup]

The Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction siteThe Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction siteThe Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction siteThe Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction siteThe Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction siteThe Coronavirus has made clear how crucial are #scientificresearch and #pharmaceutical development. That is why we decided to invest on a new #Biotech Center of Excellence and today we had the pleasure of opening the doors of the construction site.

[Chiesi Global Rare Diseases @ChiesiGRD]

Alpha-mannosidosis is an ultra-rare genetic disease caused by the lack of the enzyme called alphamannosidase (Malm, Nilssen 2019; Borgwardt et al. 2015).

Learn more: https://t.co/isLkJ8hoZ4 (international website) or https://t.co/6wTxYGavFz (US website)

[Chiesi Global Rare Diseases @ChiesiGRD]

On Sept. 1, we will host the symposium “What matters most? Improving care in Lysosomal Storage Disorders”, as part of the International Congress of the Society for the Study of Inborn Errors of Metabolism
(SSIEM). Check out the program here: https://t.co/lVCTcjSB5b

[Chiesi Global Rare Diseases @ChiesiGRD]

For over ten years, @MakeAWishFrance has been granting wishes to children, from 3 to 17 years old, suffering from serious illnesses. Granted as a family, the wish brings hope, courage and joy in difficult times.

[EFPIA @EFPIA]

The EU is a world leader in science, but when it comes to translating science into new treatments, other regions are moving faster. How can we ensure Europe is at the forefront of medical innovation? #WeWontRest

[Chiesi Global Rare Diseases @ChiesiGRD]

Giacomo Chiesi, Head of Global Rare Diseases, and Gina Cioffi, Senior Manager, Public Affairs, examine findings from our report on the economic burden of #rarediseases and the need for improved policy: https://t.co/Aq6YqsDPCL @PM360online #ChiesiGlobalRareDiseases

[nature @Nature]

From gene editing to quantum computing, here are seven technologies that are set to shake up science in 2022 https://t.co/W5WsdSuQ1c

[Chiesi Global Rare Diseases @ChiesiGRD]

Enrico Piccinini, Head of Region Europe and Emerging Markets, shares a message for the #SickleCellDisease community this #SickleCellAwarenessMonth. #SickleCellMatters #ChiesiGRD

[Society for Neuroscience (SfN) @SfNtweets]

Curious about Neuroscience 2021? Here are the answers to some of our most frequently asked questions: https://t.co/5lNe0g24e9

#SfN21

[MoMA The Museum of Modern Art @MuseumModernArt]

✉️ For our last Hey Kids! Art Crew send an artful message to a friend or family member inspired by artists #OnKawara and #MartinWong. Then share what you made with kids from around the world in virtual sessions this Thursday, August 5.

Learn more: https://t.co/xNDGGVH67c

[Chiesi Global Rare Diseases @ChiesiGRD]

Giacomo Chiesi, Head of Global Rare Diseases, discusses how companies in the pharmaceutical industry are positioned to support the global shift towards sustainability in this @statnews article: https://t.co/mceehW1f06

[I Malati Invisibili @malatinvisibili]

Mucopolisaccaridosi, il 15 maggio è la Giornata Mondiale https://t.co/Be3DrBXDOb

[EnricoPiccinini @EpPiccinini]

@PGATOUR Ehhhhhh😬😬😬

[NYT Science @NYTScience]

The emotional toll of the pandemic has left many with a sense of stagnation and emptiness. That feeling of muddling through your days, lacking motivation and struggling to focus has a name. https://t.co/dxrWNYwXzi

[Genetic Engineering & Biotechnology News @GENbio]

“Even though many knowledge gaps on the relationship between sleep and CVD [cardiovascular disease] remain to be studied in the coming years, this study provides solid evidence supporting the importance of sleep quality for a better CV health. Read more: https://t.co/S8UnaWqVDO

[Chiesi Global Rare Diseases @ChiesiGRD]

#Fabrydisease can cause symptoms such as pain and gastrointestinal issues that affect daily life, as well as complications affecting the kidneys, heart, brain and other organs that can lead to long-term challenges. Learn more: https://t.co/DJbLV0iuzT #1FDSM #RethinkFabry